| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 07/09/2008 | CN101215262A ionic liquid and its preparing process and use |
| 07/09/2008 | CN100400512C Benzoic acid derivatives as modulators of PPAR alpha and gamma |
| 07/09/2008 | CN100400487C Glucocorticoid receptor modulators |
| 07/09/2008 | CN100400040C Tripeptidyl peptidase inhibitors |
| 07/08/2008 | US7396958 Sulphonamide derivatives, their preparation and their therapeutic application |
| 07/08/2008 | US7396850 Pyrazole derivative as PPAR modulator |
| 07/08/2008 | US7396849 Chronic pain, allodynia, muscle spasticity, diarrhea, neuropathic pain; compounds have no or only minimal cardiovascular and/or sedatory activity; minimal side effects; 4-Benzo[1,2,5]thiadiazol-4-ylmethyl-1,3-dihydro-imidazole-2-thione |
| 07/08/2008 | US7396844 3-(4-amidinobenzoylamino)-4-[5-amidino-2-(2-carboxy-2-oxoethyl)phenoxy]butanoic acid; anticoagulant; blood coagulation factor X and thrombin inhibitor; cerebral infarction, thrombosis, embolism, transient ischemic attack (TIA) and subarachnoidal hemorrhage (vasospasm); ischemic heart diseases |
| 07/08/2008 | US7396843 5′-carbamoyl-1,1′-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/08/2008 | US7396831 Vanilloid receptor ligands and their use in treatments |
| 07/03/2008 | WO2008043533A3 Acyl aminoimidazoles and acyl aminothiazoles |
| 07/03/2008 | WO2008041184A3 Muscarinic receptor antagonists |
| 07/03/2008 | WO2008019030A3 Modified azole compounds as antiinfective agents |
| 07/03/2008 | US20080161373 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors |
| 07/03/2008 | US20080161351 Peroxisome proliferator-activated receptor (PPAR) delta modulators; inhibitors of inducible nitric oxide synthase (iNOS) or tumor necrosis factor (TNF); metabolic disorders, inflammatory diseases and cancer |
| 07/03/2008 | US20080161345 Aryl Sulfonamides |
| 07/03/2008 | US20080161325 e.g. N1-[3-amino-4-(3,5-difluorophenyl)-2-hydroxybutyl]-3-(butylsulfonyl)-N1-(3-ethylbenzyl)-D-alaninamide dihydrochloride; inhibitors of amyloid beta-secretase enzyme; neurodegenerative diseases: Alzheimer's, Parkinson's diseases, Down's syndrome |
| 07/03/2008 | US20080161270 Angiogenesis inhibitors |
| 07/03/2008 | CA2664118A1 Protease inhibitors |
| 07/02/2008 | EP1939184A1 1,3-diiodohydantoin compound and process for production thereof |
| 07/02/2008 | EP1939183A1 Novel nitrogenated heterocyclic compound |
| 07/02/2008 | EP1938838A1 Histamine h3 agonist for use as therapeutic agent for lipid/glucose metabolic disorder |
| 07/02/2008 | EP1937649A1 Imidazole derivatives for the treatment of anxiety and related diseases |
| 07/02/2008 | EP1730117A4 Thiourea compositions and uses thereof |
| 07/02/2008 | EP1496838A4 Substituted amides |
| 07/02/2008 | EP1333828B1 Prevention of development of dyskinesias |
| 07/02/2008 | EP1140857B1 Synthesis of histamine dihydrochloride |
| 07/02/2008 | CN101213657A Epoxy bleedout-preventing agent |
| 07/02/2008 | CN101212898A Insecticidal substituted aminoalkyl heterocyclic and heteroaryl derivatives |
| 07/02/2008 | CN100398536C Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide |
| 07/02/2008 | CN100398521C 2,5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase MMP12 |
| 07/01/2008 | US7393980 Use of a composition of an ionic nature as a substrate reagent, a composition constituting a fluorination reagent and a method using same |
| 07/01/2008 | US7393873 Arylsulfonamide derivatives |
| 06/26/2008 | WO2008076862A2 1-substituted imidazole derivatives and their use as aldosterone synthase inhibitors |
| 06/26/2008 | WO2008076754A2 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
| 06/26/2008 | WO2008076259A1 Water-soluble prodrugs of florfenicol and its analogs |
| 06/26/2008 | WO2008076256A1 Water-soluble prodrugs of chloramphenicol, thiamphenicol, and analogs thereof |
| 06/26/2008 | WO2008076046A1 Novel 2-amino-5, 5-diaryl-imidazol-4-ones |
| 06/26/2008 | WO2008076045A1 Novel 2-amino- 5-aryl-imidazol-4 -ones |
| 06/26/2008 | WO2008075565A1 Display element and method for driving the same |
| 06/26/2008 | WO2008075427A1 Clathrate compound, curing catalyst, composition for forming cured resin, and cured resin |
| 06/26/2008 | WO2008074679A2 4-imidazolines as taar's ligands |
| 06/26/2008 | WO2006104755A3 Pretreatment compositions |
| 06/26/2008 | US20080154030 combining niacin or niacinamide in the aqueous fluid with the cyclodextrin derivative; solubilizers |
| 06/26/2008 | US20080153892 1-(Urea-, thiourea- and cyanoguanidine-methylene)benzyl)imidaoles, treatment of neuronal disorders, especially Alzheimer's disease, Down Syndrome, Parkinson's disease and Huntington's disease |
| 06/26/2008 | CA2672795A1 Water-soluble prodrugs of chloramphenicol, thiamphenicol, and analogs thereof |
| 06/26/2008 | CA2672586A1 Water-soluble prodrugs of florfenicol and its analogs |
| 06/26/2008 | CA2672286A1 Organic compounds |
| 06/26/2008 | CA2672271A1 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
| 06/26/2008 | CA2671838A1 4-imidazolines as taar's ligands |
| 06/25/2008 | EP1935869A1 Retinoids for the treatment of emphysema |
| 06/25/2008 | EP1934241A2 Novel series of imidazolyl substituted steroidal and indan-1-one derivatives |
| 06/25/2008 | EP1934186A2 Renin inhibitors nitroderivatives |
| 06/25/2008 | EP1730119B1 Imidazole compounds for the treatment of neurodegenerative disorders |
| 06/25/2008 | CN100396670C N-substituted tricyclic 3-aminopyrazoles as PDFG receptor inhibitors, its pharmaceutical composition and use |
| 06/25/2008 | CN100396668C Non-imidazole aryloxypiperidines |
| 06/24/2008 | US7390908 Such as 2-[3,5-Di(2-chlorobenzyloxy)benzoyl)amino]-thiazole; for treatment of diabetes |
| 06/24/2008 | US7390829 4-(3-Hydroxymethyl-cyclohex-3-enylmethyl)-1,3-dihydro-imidzole-2-thione; side effects reduction; analgesics; chronic neuropathic and visceral pain; for reducing intraocular pressure |
| 06/19/2008 | WO2008073825A1 Lxr and fxr modulators |
| 06/19/2008 | WO2008073623A2 Soluble epoxide hydrolase inhibitors |
| 06/19/2008 | WO2008073461A2 Ion channel modulators |
| 06/19/2008 | WO2008073305A1 6-oxo.-1, 6-dihydropyrimidin-2-yls in the treatment of proliferative diseases |
| 06/19/2008 | WO2008072538A1 Organic electroluminescent device |
| 06/19/2008 | WO2008071574A1 Novel 2 -imidazoles as ligands for trace amine associated receptors (taar) |
| 06/19/2008 | WO2008071397A1 Aromatic 1,4-di-carboxylamides and their use |
| 06/19/2008 | WO2007062316A3 Trans-3,5-disubstitutedpyrrolidine: organocatalyst for anti-mannich reactions |
| 06/19/2008 | US20080146816 Polycarbazole ; optoelectronics, signal processing, data storage; ability to change colour reversibly under the effect of light radiation |
| 06/19/2008 | US20080146803 Antibiotics containing borinic acid complexes and methods of use |
| 06/19/2008 | US20080146797 Process for synthesizing heterocyclic compounds |
| 06/19/2008 | US20080146740 Process for the controlled increase in the molecular weight of polyethylenes |
| 06/19/2008 | US20080146642 Propanesulfonic acid amino acid prodrugs that can deliver 3-amino-1-propanesulfonic acid (3APS) by minimizing metabolism associated with that drug, particularly compounds that block or protect amino group of 3APS such that it avoids metabolism by transaminases or monoamine oxidase; Alzheimer's disease |
| 06/19/2008 | US20080146640 Water-Soluble Prodrugs of Chloramphenicol, Thiamphenicol, and Analogs Thereof |
| 06/19/2008 | US20080146635 Selective to alpha2B and/or alpha2C adrenergic receptors, minimal cardivascular and/or sedatory activity; treating pain, visceral pain, neuropathic pain, corneal pain, glaucoma, elevated intraocular pressure, ischemic neuropathies, neurodegenerative diseases, diarrhea, nasal congestion |
| 06/19/2008 | US20080146634 2-imidazoles |
| 06/19/2008 | US20080146627 Thiazole, oxazole, imidazole, isoxazole and isoxazoline derivatives, e.g., butyl 2-(4-[1,1'-biphenyl]-4-yl-1H-imidazol-2-yl)ethylcarbamate inhibit lipidic peroxidation and monoamine oxidase and modulate sodium channels and are used for treating neurodegenerative disorders or pain. |
| 06/19/2008 | US20080146523 Imidazole derivatives |
| 06/19/2008 | CA2672617A1 Novel 2-imidazoles as ligands for trace amine associated receptors (taar) |
| 06/19/2008 | CA2670726A1 6-oxo-1, 6-dihydropyrimidin-2-yls in the treatment of proliferative diseases |
| 06/18/2008 | EP1932834A1 Aromatic 1,4-DI-Carboxylamides and their use |
| 06/18/2008 | EP1931655A2 A process for the preparation of sartan derivatives and intermediates useful in such process |
| 06/18/2008 | EP1931627A1 Amino-alkyl-amide derivatives as ccr3 receptor ligands |
| 06/18/2008 | EP1931348A2 Monocyclic and bicyclic compounds and methods of use |
| 06/18/2008 | CN101203522A Antineoplastic compounds and pharmaceutical compositions thereof |
| 06/18/2008 | CN100395234C Novel CB1 receptour inverse agonists |
| 06/17/2008 | US7388098 Dynamic resolution of isomers and resolved isomers |
| 06/12/2008 | WO2008070336A2 Hypoxia-selective, weakly basic 2-nitroimidazole delivery agents and methods of use thereof |
| 06/12/2008 | WO2008067687A1 The salts of imidazol-5-carboxylic acid derivatives, preparation methods and use therrof |
| 06/12/2008 | WO2007110237A3 Amide derivatives and their application for the treatment of g protein related diseases |
| 06/12/2008 | US20080139811 Reacting an amino, hydroxy substituted amide with a heterocyclic substituted carboxylic acid to produce (2S,3S,5S)-2-(2,6-Dimethylphenoxyacetyl) amino-3-hydroxy-5-[2S-1-imidazolidin-2-onyl)-3-methyl-butanoyl] amino-1,6-diphenylhexane; inhibitors of HIV infection |
| 06/12/2008 | US20080139636 Adamantane derivatives |
| 06/12/2008 | US20080139533 Substituted 4-imidazoles |
| 06/12/2008 | US20080139481 High binding activity modified peptides; blood stability, receptor selectivity, barrier crossing; N-terminus moieties |
| 06/12/2008 | US20080139455 (2S,3S,E)-2-amino-14,14-difluoro-3-hydroxytetradec-6-enoic acid; serine palmitoyl transferase ; insulin resistance, pancreatic beta cell apoptosis, obesity, pro-thrombotic conditions, myocardial infarction, hypertension, dyslipidemia |
| 06/12/2008 | US20080138704 Material for Electrolytic Solution, Ionic Material-Containing Composition and Use Thereof |
| 06/12/2008 | US20080138329 Inhibitors of Dna Methylation in Tumor Cells |
| 06/11/2008 | EP1930335A1 Cephalosporines having cyclic aminoguanidine substituents as Antibiotics |
| 06/11/2008 | EP1928841A1 Amino-5- ý4- (difluoromethoxy) phenyl¨-5-phenylimidazolone compounds as inhibitors of the beta-secretase (bace) |
| 06/11/2008 | EP1928822A1 Violet laser excitable dyes and their method of use |
| 06/11/2008 | EP1463501B1 Cis-imidazolines as mdm2 inhibitors |
| 06/11/2008 | CN101195606A Method for synthesizing oxazoline ketone and cyclic urea compounds |